Showing results (251-260 of 1,230) with videos related to
Sort By:
Pageof 123
Cancer Treatment and Research Communications|July 8, 2026
Survival outcomes in EGFR-mutant versus wild-type locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy alone in the pre-PACIFIC/LAURA trial era: A systematic review and meta-analysis using reconstructed individual patient dataSatoru Ochiai, Takamitsu Mase, Yutaka Toyomasu, et al.Cancer Treatment and Research Communications|June 29, 2026
Association of glucagon-like peptide 1 receptor and the aggressiveness of extrahepatic cholangiocarcinomaYongyot Varathorn, Mathawee Chanamarnjuntho, Ronnakrit Trakoonsenathong, et al.Cancer Treatment and Research Communications|July 4, 2026
Distinct molecular features of ovarian adult granulosa cell tumors and co-occurring primary malignancies-an exploratory case seriesSven Karstensen, Tim Svenstrup Poulsen, Claus Høgdall, et al.Cancer Treatment and Research Communications|July 14, 2026
Performance status 2 or higher in EMA labels for advanced non-small-cell lung cancer: a cross-sectional SmPC analysisJavier-David Benitez-Fuentes, Elena Navarro Vicente, Antonio David Lazaro Sanchez, et al.Cancer Treatment and Research Communications|July 25, 2026
Concurrent preoperative eribulin and radiation for resectable retroperitoneal liposarcoma: a phase 1B studyLara E Davis, Limin Zhu, Skye C Mayo, et al.Cancer Treatment and Research Communications|August 5, 2026
BRAF V600E Co-mutations predict aggressive clinicopathological features in Chinese patients with differentiated thyroid cancer: A multicenter cohort studyJing Du, Bo Guo, Yunpeng Zhang, et al.Cancer Treatment and Research Communications|August 6, 2026
Beyond the clinical trial: Real-world treatment patterns and drivers of PD-(L)1 therapy use in first-line metastatic NSCLCSiobhan Halloran, Salman R Punekar, Mark Guinter, et al.Cancer Treatment and Research Communications|August 14, 2026
Molecular functions, clinical correlates, and therapeutic prospects of B7-H3 expression in colorectal cancer: A systematic reviewNouran Alwisi, Mohammad Hamid, Dahab Ghith, et al.Cancer Treatment and Research Communications|July 17, 2026
Circulating tumor DNA to predict the risk of venous thromboembolism in locally advanced rectal cancerLorenzo Gervaso, Davide Ciardiello, Samuele Frassoni, et al.Cancer Treatment and Research Communications|August 20, 2026
Financial burden of immune checkpoint inhibitor maintenance therapy in Japan: a real-world cost analysis from an academic medical centerShinji Tamada, Wataru Obara, Satoshi S NishizukaPageof 123